Immunogenicity and Safety of GSK Biologicals' Boostrix Polio Vaccine in 3 and 4-year-old Children
Clinical trial NCT01245049 · COMPLETED
Trial details
- NCT number
- NCT01245049
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2011-04-01
- Primary completion
- 2012-03-27
- Enrollment
- 387
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.